Seguir
Eugeen Vanmechelen
Eugeen Vanmechelen
CSO, ADx NeuroSciences
Dirección de correo verificada de adxneurosciences.com
Título
Citado por
Citado por
Año
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
F Hulstaert, K Blennow, A Ivanoiu, HC Schoonderwaldt, ...
Neurology 52 (8), 1555-1555, 1999
9021999
Tau protein in cerebrospinal fluid
K Blennow, A Wallin, H Ågren, C Spenger, J Siegfried, E Vanmechelen
Molecular and chemical neuropathology 26 (3), 231-245, 1995
8871995
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen, L Minthon, P Davidsson, E Vanmechelen, H Vanderstichele, ...
Archives of neurology 58 (3), 373-379, 2001
7342001
Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease
N Andreasen, C Hesse, P Davidsson, L Minthon, A Wallin, B Winblad, ...
Archives of neurology 56 (6), 673-680, 1999
7181999
Detection of proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme‐linked immunosorbent assay
M Vandermeeren, M Mercken, E Vanmechelen, J Six, A Van de Voorde, ...
Journal of neurochemistry 61 (5), 1828-1834, 1993
6111993
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
M Goedert, R Jakes, E Vanmechelen
Neuroscience letters 189 (3), 167-170, 1995
5681995
Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study
H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ...
Archives of general psychiatry 61 (1), 95-102, 2004
5502004
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen, H Vanderstichele, P Davidsson, E Van Kerschaver, ...
Neuroscience letters 285 (1), 49-52, 2000
5362000
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse, L Rosengren, N Andreasen, P Davidsson, H Vanderstichele, ...
Neuroscience letters 297 (3), 187-190, 2001
5212001
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ...
Archives of neurology 67 (8), 949-956, 2010
5072010
Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values
M Sjogren, H Vanderstichele, H Ågren, O Zachrisson, M Edsbagge, ...
Clinical chemistry 47 (10), 1776-1781, 2001
4872001
Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology
A Olsson, H VANDERSticHELE, N Andreasen, G De Meyer, A WALLiN, ...
Clinical chemistry 51 (2), 336-345, 2005
4672005
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein
M Goedert, R Jakes, RA Crowther, P Cohen, E Vanmechelen, ...
Biochemical Journal 301 (3), 871-877, 1994
4271994
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ...
Archives of neurology 69 (11), 1445-1452, 2012
4222012
Standardization of measurement of β-amyloid (1-42) in cerebrospinal fluid and plasma
H Vanderstichele, EV Kerschaver, C Hesse, P Davidsson, MA Buyse, ...
Amyloid 7 (4), 245-258, 2000
3762000
CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease
K Blennow, E Vanmechelen, H Hampel
Molecular neurobiology 24 (1), 87-97, 2001
3732001
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 179, 2015
3672015
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
N Andreasen, L Minthon, E Vanmechelen, H Vanderstichele, P Davidsson, ...
Neuroscience letters 273 (1), 5-8, 1999
3201999
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
O Hansson, H Zetterberg, E Vanmechelen, H Vanderstichele, ...
Neurobiology of aging 31 (3), 357-367, 2010
3172010
Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
N Sergeant, A Bretteville, M Hamdane, ML Caillet-Boudin, P Grognet, ...
Expert review of proteomics 5 (2), 207-224, 2008
3142008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20